WhiteBook2_Part2 - 37

Appendix
Austrian Society of Gastroenterology and Hepatology
Develop new capacities to
reduce burden
Immunology
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Drug therapy
Pathology and
physiopathology
Epidemiology
Epidemiology
Epidemiology
Improve performance of existing
capacities to reduce burden
Therapeutics
(other) e.g.
radiotherapy,
rehabilitation
British Society of Gastroenterology
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Aetiology
Aetiology
Diagnosis
Health care
quality, access,
and evaluation
Health care
quality, access,
and evaluation
Bulgarian Society of Gastroenterology
Assess burden of disease and its
determinants
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Epidemiology
Diagnosis
Health care
quality, access,
and evaluation
Therapeutics
(other) e.g.
radiotherapy,
rehabilitation
Virology
Irritable bowel syndrome
(K58)
Crohn's disease and
ulcerative colitis (K50-K51)
Crohn's disease and
ulcerative colitis (K50-K51)
All diseases of the digestive
system (K20-K93)
Viral hepatitis (B15-B19)
Young Gastroenterology
Surveys and Research if IBS
burden
Red Flags with Fecal
calprotectin as screening tools
for IBD
ECCO UR-CARE initiative with
creating National IBD registry
Multicentral study for Quality
indicators for EMR, ERCP, EUS
Eradicate HCV and follow-up
patients for HCC after SVR
All diseases of the digestive
system (K20-K93)
Other diseases of liver (K71K77)
Other
diseases of liver (K71K77)
Azerbaijan
Gastroenterology and Hepatology Association
Assess burden of disease and its
determinants
Assess burden of disease and its
determinants
Assess burden of disease and its
determinants
Crohn's disease and
ulcerative colitis (K50-K51)
Diseases of oesophagus
(K20-K23)
Viral hepatitis (B15-B19)
Other diseases of the
digestive system (K90.1K93)
Crohn's
disease and
ulcerative colitis (K50-K51)
Irritable bowel syndrome
(K58)
All diseases of the digestive
system (K20-K93)
Alcohol-related liver disease
(K70)
Diseases of pancreas (K85K86,
K87.1)
Microbiome, mucosal
immunology, gut-liver-axis
Disease-modifying therapies for
chronic liver diseases
Pathophysiology of chronic
liver diseases
Features of IBD in Azerbaijan
The prevalence of GERD in
Azerbaijan
The prevalence of hepatitis B
and D in Azerbaijan
Advanced endoscopic
techniques in Azerbaijan
Further the understanding of
underlying causes of IBD
Improving understanding of IBS
Early diagnostics/ Precision
Medicine
Improving early diagnosis,
treating alcohol dependence
Reduce significant variation in
quality of care
White Book 2: Part 2
34
WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2
